INDICATIONS AND USAGE CERVARIX® is indicated for the prevention of the following diseases caused by oncogenic human papillomavirus (HPV) types 16 and 18 [see Clinical Studies (14)]: Cervical cancer Cervical intraepithelial neoplasia (CIN) grade 2 or worse and adenocarcinoma in situ, and Cervical intraepithelial neoplasia (CIN) grade 1. CERVARIX is approved for use in females […]
Synoptic Overview: Issues in Immunization Theory and Practice
Prepared by: Raymond Obamsowin November 2009 IMMUNIZATION THEORY ISSUES: Theory: Vaccination is the injection of antigenic material, such as pathogen derived foreigh proteins and toxic adjuvants into the body, to initiate a “learned” immune system response in order to prevent particular diseases. Memory T cells (cell-mediated immunity) and Memory B cells (humoral-mediated immunity) learn to […]
Physicians Avoid Recommending HPV Vaccine in Girls Aged 11 to 12 Years
By: Fran Lowry From Medscape Medical News August 4, 2010 — The majority of pediatricians and family physicians in the United States are offering the human papillomavirus (HPV) vaccine to their older adolescent patients, but fewer are recommending the vaccine to their younger patients (those aged 11 to 12 years) — the age group that […]
Effect of the Menstrual Cycle and Hormonal Contraceptives on Human Papillomavirus
Channa E. Schmeink, MD, Leon F. Massuger, MD, PhD, Charlotte H. Lenselink, MD, PhD, Wim G. Quint, PhD, Willem J. Melchers, PhD, and Ruud L. Bekkers, MD, PhD (Obstet Gynecol 2010;116:67–75) OBJECTIVE: To estimate the effect of the menstrual cycle and oral contraceptive pill (OCP) use on the prevalence, incidence, and persistence of human papillomavirus(HPV). […]
Developing Nations, Including India, Capable of Producing Lower-Cost HPV Vaccine
By: Tanya Thomas on July 12, 2010 at 10:39 AM Vaccine manufacturers in India and other developing nations can produce a lower-cost HPV vaccine despite the complicated array of patent protections on the technology, according to an Indian-origin scientist at the Duke Institute for Genome Sciences and Policy. At a cost of at least 300dollars […]
- « Previous Page
- 1
- …
- 49
- 50
- 51
- 52
- 53
- …
- 60
- Next Page »
